We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SEZL:NASDAQSezzle Inc. Analysis

Data as of 2026-09-01 - not real-time

$114.14

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Sezzle Inc. is neutral at $114.14, with no clear ordering between short and long averages. Over a rolling month the price has lost 36.4%. Momentum indicators put RSI at 36.2 (approaching oversold) with MACD reading bullish. The recent range runs from support at $112.41 up to resistance at $184.21.
The shares look fair, trading on 25.0 times earnings above a sector average of 16.8. Sell-side targets cluster 47.2% above the current quote. Revenue is growing at 51.7% on a 30.3% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 134.3%, a beta of 2.39 and a maximum drawdown of 45.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

In early August 2026, Sezzle Inc. raised its 2026 total revenue growth guidance to the top of its prior 30%–35% range...Sezzle Inc SEZL reports 51.7% revenue growth and raises full-year outlook amid surging subscriber engagement and new...Sezzle Inc. SEZL delivered earnings and revenue surprises of +18.95% and +14.88%, respectively, for the quarter ended...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 97.15
  • MACD momentum is positive
  • 30-day price change of -36.4%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 25.0 versus sector average of 16.8
  • Trading above the 200-day average of 97.15
  • Analyst targets imply +47.2% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 25.0 versus sector average of 16.8
  • Analyst targets imply +47.2% versus the current price
  • Profit margin of 30.3% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth51.70%
Profit Margin30.35%
P/E Ratio25.0
ROE88.85%
ROA48.79%
Debt/Equity52.42
P/B Ratio16.5
Op. Cash Flow$275.6M
Free Cash Flow$100.5M
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI36.2
Support$112.41
Resistance$184.21
MA 20$127.33
MA 50$152.28
MA 200$97.15
MACDBullish
VolumeDecreasing
Fear & Greed Index93.02

Valuation

Fair Value$102.39
Target Price$168.00
Upside/Downside47.19%
GradeFair
TypeGrowth

Risk Assessment

Beta2.39
Volatility134.33%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.